Year: 2023
Type: conference-abstract
Abstract: New Zealand and Australia have led the world with progressive tobacco control policies for many years.Both countries have seen positive results, with marked declines in smoking prevalence overall.But not all population groups have experienced the rates of decline and flow-on health benefits equally.In New Zealand, M aori smoking prevalence has fallen yearly for over a decade but remains more than double that of non-M aori.This persisting inequitya breach of the New Zealand government's obligations to M aori to achieve equal health outcomesunderpins a new and radical divergence in tackling tobacco between our two countries.While Australia has adopted a business-as-usual approach, New Zealand's Tobacco Control Action Plan for a Smokefree Aotearoa by the year 2025, supported by the Smokefree Environments and Regulated Products Amendment Act passed in December 2022, outlines a radical legislative agenda: from 1 July 2024 there will be a marked reduction in the number of retailers able to sell smoked tobacco products; from 1 April 2025 the nicotine content of tobacco products must be reduced to 0.8 mg/g of tobacco, effectively to non-addictive levels; and from 1 January 2027, the sale of smoked tobacco products to anyone born on or after 1 January 2009 will be prohibited.Greater investment in M aori tobacco control leadership and ramped-up smoking cessation support in the communities with the highest smoking prevalence will support these strategies.But one other approach diverges dramatically from Australia's current direction: in New Zealand, vaping products are regulated as consumer products, are widely available and vaping is actively promoted by the government as an evidence-based quit-smoking strategy.My presentation explores the divergence in approaches between our countries and outlines the rationale behind New Zealand's radical Action Plan.I will also argue that vaping is vital to the success of New Zealand's strategy.Keynote Address 2.
Source: Drug and Alcohol Review
DOI: 10.1111/dar.13749
Author: Presenter's email:
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,220
Funders: U.S. Department of Justice, Indivior, Australian Government, University of New South Wales, University of Sydney, Department of Health and Aged Care, Australian Government, National Coronial Information System, Seqirus, Medical Research Council, National Health and Medical Research Council, Sydney Medical School, National Drug and Alcohol Research Centre
Awards: A Centre for Research Excellence: Building Indigenous research capacity to find solutions to alcohol problems, Working with Indigenous services and communities to reduce the harms from alcohol, Better methods to collect self-report data on alcohol use behaviours from Aboriginal and Torres Strait Islander Australians, Increasing uptake of evidence-based management of unhealthy alcohol use in Aboriginal primary health care services, G4306853284, Quantifying and reducing the burden of alcohol and illicit drug use, Better data on methamphetamines and other drugs among Indigenous Australians to inform policy and practice, G8415457339, Quantifying and reducing the burden of new and emerging psychoactive substances in Australia, Improving Knowledge and Interventions to reduce and prevent substance use related harms
OpenAlex ID: W4388247689